Anjon Biologics Inc.

LAS VEGAS, NV · CIK 0001490554 · Biotech · Private

Biopharmaceutical therapeutics and biologics for human, animal, and agricultural applications

anjonbiologics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
1 Form D · May 2010
197 months since last filing
Contracts
—
No federal contracts on record
Patents
9
1 granted · 8 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1560Karuna Therapeutics——
1561Sudo Biosciences—$63M
1562TROPHOGEN INC——
1563Anjon Biologics Inc.——
1564STEM PHARM, INCORPORATED——
1565RELMADA THERAPEUTICS, INC.—$33M
1566CELLOLOGI, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Charlotte BreezeDirector · Executive Officer
  • Robert BreezeDirector · Executive Officer
  • Barry FinerExecutive Officer

Patents

USPTO · 1 granted of 9
  • Mineral Based Compositions And Use Thereofgranted
  • Compositions For Skincare And Use Thereofapplication
  • Anti-pathogenic Compositionsapplication
  • Anti-pathogenic Compositionsapplication
  • Mineral Based Compositions And Use Thereofapplication
  • Compositions For Skincare And Use Thereofapplication
  • Compositions For Skincare And Use Thereofapplication
  • Antipathogenic Compositionsapplication
  • Mineral Based Compositions And Use Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.